X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (942) 942
Publication (66) 66
Book / eBook (25) 25
Conference Proceeding (25) 25
Book Chapter (11) 11
Book Review (9) 9
Patent (9) 9
Report (8) 8
Magazine Article (7) 7
Web Resource (6) 6
Data Set (2) 2
Dissertation (1) 1
Government Document (1) 1
Newsletter (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (264) 264
male (183) 183
female (152) 152
index medicus (151) 151
animals (123) 123
adult (103) 103
middle aged (83) 83
neurosciences (80) 80
mice (77) 77
aged (63) 63
neuromuscular junction (48) 48
mutation (43) 43
acoustics (37) 37
adolescent (36) 36
genetics & heredity (35) 35
language (35) 35
psychoacoustics (33) 33
rats (33) 33
research (33) 33
analysis (31) 31
multidisciplinary sciences (30) 30
noise (30) 30
psycholinguistics (29) 29
education (28) 28
time factors (28) 28
clinical neurology (27) 27
speech perception (27) 27
electrophysiology (26) 26
biochemistry & molecular biology (25) 25
disease models, animal (25) 25
mutations (25) 25
netherlands (25) 25
young adult (25) 25
child (22) 22
phenotype (22) 22
research article (22) 22
transmitter release (22) 22
antibodies (21) 21
educational technology (21) 21
gangliosides - immunology (21) 21
immunology (21) 21
physics, condensed matter (21) 21
proteins (21) 21
abridged index medicus (20) 20
auditory threshold (20) 20
gene (20) 20
identification (20) 20
neurotransmitter release (20) 20
atomic force microscopy (19) 19
crystallography (19) 19
electroencephalography (19) 19
acetylcholine - metabolism (18) 18
article (18) 18
child, preschool (18) 18
foreign countries (18) 18
guillain-barre-syndrome (18) 18
myasthenia gravis (18) 18
neuromuscular junction - metabolism (18) 18
perception (18) 18
physiological aspects (18) 18
autoimmunity (17) 17
disease (17) 17
follow-up studies (17) 17
genes (17) 17
immunoglobulin g (17) 17
medicine (17) 17
mice, knockout (17) 17
neurology (17) 17
pedigree (17) 17
perceptual masking (17) 17
speech reception threshold test (17) 17
synaptic transmission (17) 17
cells, cultured (16) 16
expression (16) 16
glycosylation (16) 16
kinetics (16) 16
miller-fisher-syndrome (16) 16
neuroimaging (16) 16
neuromuscular junction - physiopathology (16) 16
neuromuscular-junction (16) 16
ophthalmology (16) 16
science (16) 16
brain (15) 15
genetic aspects (15) 15
hearing aids (15) 15
mechanisms (15) 15
neuromuscular junction - immunology (15) 15
physics, applied (15) 15
protein (15) 15
autoantibodies (14) 14
chemistry, physical (14) 14
computer science, interdisciplinary applications (14) 14
crystallization (14) 14
eeg (14) 14
ganglioside (14) 14
genetics (14) 14
in vitro techniques (14) 14
journal article (14) 14
neuromuscular junction - drug effects (14) 14
phonetics (14) 14
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
Online Resources - Online (6) 6
Art - Library use only (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
OISE - Stacks (4) 4
UTL at Downsview - May be requested (3) 3
Art - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Scarborough - Stacks (2) 2
Art - Oversize (1) 1
Gerstein Science - Stacks (1) 1
OISE - Reference (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article